Immunovant, Inc.
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fra…
Biotechnology
US, New York [HQ]
Lobbying · US Senate · Influence
Lobbying Analysis
Lobbying · US Senate · Influence
Immunovant, Inc. has no lobbying expenses in our database.
| FY | Quarter | Lobby Expense [in mil. $] | Filing | Report Time |
|---|---|---|---|---|
| No data |